These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 6650339

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Thalidomide and the treatment of Behçet's syndrome].
    Couzigou P, Doutre MS, Houdée G, Richard-Molard B, Fleury B, Amouretti M, Beylot C, Béraud C.
    Gastroenterol Clin Biol; 1983; 7(8-9):751. PubMed ID: 6618080
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of Behcet's syndrome with thalidomide].
    Hamza M, Chaffai M, Ben Ayed H.
    Nouv Presse Med; 1982 Mar 27; 11(14):1080-1. PubMed ID: 7079129
    [No Abstract] [Full Text] [Related]

  • 9. [Thalidomide and ulcerative colitis in Behçet's disease].
    Patey O, Charasz N, Roucayrol AM, Malkin JE, Lafaix C.
    Gastroenterol Clin Biol; 1989 Jan 27; 13(1):104. PubMed ID: 2925035
    [No Abstract] [Full Text] [Related]

  • 10. Pyoderma gangrenosum associated with Behçet's syndrome--response to thalidomide.
    Munro CS, Cox NH.
    Clin Exp Dermatol; 1988 Nov 27; 13(6):408-10. PubMed ID: 3256462
    [No Abstract] [Full Text] [Related]

  • 11. [Thalidomide--a possible alternative as an immunomodulating agent].
    Lakartidningen; 1989 Nov 29; 86(48):4260-2. PubMed ID: 2593763
    [No Abstract] [Full Text] [Related]

  • 12. [Urinary incontinence secondary to thalidomide use].
    Ahrich N, Meziane M, Khatibi B, Senouci K, Hassam B, Benzekri L.
    Ann Dermatol Venereol; 2008 Nov 29; 135(11):776-7. PubMed ID: 19061661
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Successful thalidomide treatment of severe infantile Behçet disease.
    Brik R, Shamali H, Bergman R.
    Pediatr Dermatol; 2001 Nov 29; 18(2):143-5. PubMed ID: 11358558
    [Abstract] [Full Text] [Related]

  • 18. Thalidomide and cell mediated immunity in Behçet's disease.
    Hamza M, Hamzaoui K, Ayed K, Eleuch M, Zribi A.
    Clin Rheumatol; 1987 Dec 29; 6(4):608-9. PubMed ID: 3449313
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of recurrent perforating intestinal ulcers with thalidomide in Behçet's disease.
    Sayarlioglu M, Kotan MC, Topcu N, Bayram I, Arslanturk H, Gul A.
    Ann Pharmacother; 2004 May 29; 38(5):808-11. PubMed ID: 15010523
    [Abstract] [Full Text] [Related]

  • 20. Treatment of colitis in Behçet's disease with thalidomide.
    Postema PT, den Haan P, van Hagen PM, van Blankenstein M.
    Eur J Gastroenterol Hepatol; 1996 Sep 29; 8(9):929-31. PubMed ID: 8889464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.